Jones Financial Companies
CRSP icon

Jones Financial Companies’s CRISPR Therapeutics CRSP Stock Holding History

Jones Financial Companies’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Buy
63,666
+6,177
+11% +$326K ﹤0.01% 1278
2025
Q4 		$3.01M Buy
57,489
+12,774
+29% +$765K ﹤0.01% 815
2025
Q3 		$2.76M Buy
44,715
+14,948
+50% +$858K ﹤0.01% 764
2025
Q2 		$1.41M Buy
29,767
+8,828
+42% +$342K ﹤0.01% 870
2025
Q1 		$775K Buy
20,939
+9,678
+86% +$410K ﹤0.01% 959
2024
Q4 		$443K Buy
11,261
+5,022
+80% +$237K ﹤0.01% 1038
2024
Q3 		$295K Buy
6,239
+2,365
+61% +$120K ﹤0.01% 1005
2024
Q2 		$209K Buy
3,874
+2,709
+233% +$157K ﹤0.01% 822
2024
Q1 		$79.4K Buy
+1,165
New +$83.4K ﹤0.01% 639

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return